-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- This week in PLOS Biology in Work In Progress
- Fossilized Footprints Lead Scientists Down a Prehistoric Path in Work In Progress
- Why Measles Isn't Just An Anti-Vaxxer Problem in Work In Progress
- How will the Ebola epidemic end? in Work In Progress
- Rising Wealth Inequality and NCDs - What's the Link? in Work In Progress
You may also be interested in:
Click to go to this PLOS Medicine collection
Blog Archives
Cancer Care’s “Culture of Excess”
Category: cancer, Cost-Effectiveness Analysis, Healthcare
Tagged biomarkers, cancer, cancer care, cancer cost, complex adaptive systems, European Multidisciplinary Cancer Congress, FiercePharma, incremental cost-effectiveness ratios, moral hazard, Richard Sullivan, The Huffington Post, The Lancet Oncology
3 Comments
Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013.